The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes. [electronic resource]
Producer: 20060608Description: 665-76 p. digitalISSN:- 0145-2126
- Anthracyclines -- administration & dosage
- Antigens, CD34 -- biosynthesis
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Asparaginase -- administration & dosage
- Blast Crisis -- drug therapy
- Burkitt Lymphoma -- drug therapy
- Child
- Child, Preschool
- Cortisone -- administration & dosage
- DNA-Binding Proteins -- biosynthesis
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Leukemic -- genetics
- Humans
- Infant
- Male
- Oligonucleotide Array Sequence Analysis -- methods
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Predictive Value of Tests
- Proto-Oncogene Proteins c-bcr -- biosynthesis
- Transcription Factors -- biosynthesis
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.